18578 A pooled 48-week analysis of brodalumab on a marker of inflammation in patients with psoriasis and potential indicators of early nonalcoholic fatty liver disease
Prussick, Ronald, Menter, M. Alan, Wu, Jashin J., Heimanson, Zeev, Jacobson, Abby, Israel, Robert J.Volume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.498
Date:
December, 2020
File:
PDF, 625 KB
2020